Artwork

Kandungan disediakan oleh Oleksandr Yagensky. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Oleksandr Yagensky atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

Ep#018: Bringing Proteomics One Step Closer to Clinics with Dr. Oliver Rinner

43:27
 
Kongsi
 

Manage episode 275595016 series 2800366
Kandungan disediakan oleh Oleksandr Yagensky. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Oleksandr Yagensky atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
We are back! The first episode of Season 2 of the Personalized Medicine Podcast is out! In this episode, our host Oleksandr Yagensky sat down with Dr. Oliver Rinner, co-founder, and CEO of Biognosys, a proteomics technology company. We discussed the growing role of proteomics in healthcare, its impact on biomarker discovery, and the development of new therapeutics.
Together with Oliver, we talk about:
◦ Startup story of Biognosys
◦ Transitioning from academia to entrepreneurship
◦ Impact of proteomics on pharma industry
◦ Role of proteomics in biomarker discovery
◦ Differences between targeted and discovery mass spectrometry
◦ Role of AI and ML in the analysis of OMICs data
◦ How can proteomics take up a mainstream role in clinical diagnostics?
◦ The outlook on the personalized medicine of the future
Get in touch with Oliver:
◦ Twitter: @oliverrinner, @biognosys
◦ Linkedin: https://www.linkedin.com/in/orinner/
◦ Web: https://biognosys.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
  continue reading

48 episod

Artwork
iconKongsi
 
Manage episode 275595016 series 2800366
Kandungan disediakan oleh Oleksandr Yagensky. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Oleksandr Yagensky atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
We are back! The first episode of Season 2 of the Personalized Medicine Podcast is out! In this episode, our host Oleksandr Yagensky sat down with Dr. Oliver Rinner, co-founder, and CEO of Biognosys, a proteomics technology company. We discussed the growing role of proteomics in healthcare, its impact on biomarker discovery, and the development of new therapeutics.
Together with Oliver, we talk about:
◦ Startup story of Biognosys
◦ Transitioning from academia to entrepreneurship
◦ Impact of proteomics on pharma industry
◦ Role of proteomics in biomarker discovery
◦ Differences between targeted and discovery mass spectrometry
◦ Role of AI and ML in the analysis of OMICs data
◦ How can proteomics take up a mainstream role in clinical diagnostics?
◦ The outlook on the personalized medicine of the future
Get in touch with Oliver:
◦ Twitter: @oliverrinner, @biognosys
◦ Linkedin: https://www.linkedin.com/in/orinner/
◦ Web: https://biognosys.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
  continue reading

48 episod

すべてのエピソード

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas